Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

Section of Molecular Medicine, University of Sheffield, United Kingdom.
Proceedings of the National Academy of Sciences (Impact Factor: 9.81). 05/1997; 94(7):3195-9. DOI: 10.1073/pnas.94.7.3195
Source: PubMed

ABSTRACT Tumor necrosis factor alpha (TNF alpha) is a potent immunomodulator and proinflammatory cytokine that has been implicated in the pathogenesis of autoimmune and infectious diseases. For example, plasma levels of TNF alpha are positively correlated with severity and mortality in malaria and leishmaniasis. We have previously described a polymorphism at -308 in the TNF alpha promoter and shown that the rare allele, TNF2, lies on the extended haplotype HLA-A1-B8-DR3-DQ2, which is associated with autoimmunity and high TNF alpha production. Homozygosity for TNF2 carries a sevenfold increased risk of death from cerebral malaria. Here we demonstrate, with reporter genes under the control of the two allelic TNF promoters, that TNF2 is a much stronger transcriptional activator than the common allele (TNF1) in a human B cell line. Footprint analysis using DNase I and B cell nuclear extract showed the generation of a hypersensitive site at -308 and an adjacent area of protection. There was no difference in affinity of the DNA-binding protein(s) between the two alleles. These results show that this polymorphism has direct effects on TNF alpha gene regulation and may be responsible for the association of TNF2 with high TNF alpha phenotype and more severe disease in infections such as malaria and leishmaniasis.


Available from: Anthony G Wilson, Jun 02, 2015
1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: Several studies have indicated an association between tumor necrosis factor-alpha (TNF-α) or interleukin (IL)-6 gene polymorphisms and lung cancer risk. However, the conclusions remain controversial. An English literature screening about case-control trials with regard to TNF-α (-308G/A) or IL-6 (174G/C) polymorphisms and lung cancer susceptibility was performed on PubMed, EMBASE, and EBSCO until November 2012. The pooled odds ratio (OR) and 95% confidence intervals (CI) were calculated using STATA 11.0. Sensitivity analysis was performed by sequential omission of individual studies. Publication bias was evaluated by Egger's linear regression test and funnel plots. Eight eligible studies, including 1,690 patients and 1,974 controls, were identified in this meta-analysis. Compared with the control, no significant association was revealed between TNF-α-308G/A (GG + GC vs. CC: OR = 1.10, 95% CI: 0.73 to 1.64; GG vs. GC + CC: OR = 1.02, 95% CI: 0.81 to 1.27; GC vs. CC: OR = 1.13, 95% CI: 0.73 to 1.77; GG vs. CC: OR = 1.04, 95% CI: 0.80 to 1.36; G vs. C: OR = 1.03, 95% CI: 0.90 to 1.18) or IL-6 174G/C (GG + GC vs. CC: OR = 1.10, 95% CI: 0.73 to 1.64; GG vs. GC + CC: OR = 1.02, 95% CI: 0.81 to 1.27; GC vs. CC: OR = 1.13, 95% CI: 0.73 to 1.77; GG vs. CC: OR = 1.04, 95% CI: 0.80 to 1.36; G vs. C: OR = 1.03, 95% CI: 0.90 to 1.18) and lung cancer risk. The pooled OR remained unchanged after removing the maximum-weight study and no publication bias was observed. The study raises the possibility of no correlation between the polymorphisms of the two genes and lung cancer susceptibility. However, further researches with large-sample or subgroup analyses are necessary to validate the conclusions.
    03/2015; 20(1):28. DOI:10.1186/s40001-015-0113-9
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Compounds of the major histocompatibility complex (MHC) are integral for effective vertebrate adaptive immune response, and are also implicated as cues for sexual selection. The evidence for this is supportive of MHC-based preference for diverse and dissimilar mating partners, in a range of vertebrates from fish to nonhuman primates. However, the evidence for a similar role of these genes and the evolutionary benefits of their diversity in human mate choice has been more controversial. Here, we review the results of 34 primary studies on MHC-mediated mate choice in humans and nonhuman primates in an effort to understand what processes may underscore, or belie, such differences. Both human and nonhuman primate studies show evidence of mate selection for MHC-dissimilarity and diversity, with fewer results in support of mate selection for optimal diversity or for specific " good gene ". In general, stronger support comes from female-choice studies as opposed to male-choice studies (though male preferences and choice are investigated less often). This review suggests that the majority of mate choice results from contemporary human studies are consistent with our evolutionary history, but also reveals that only in humans do we find evidence for preference for mates with similar MHC composition. Overall, we show that contextual nuances, namely, population structure, multiple sensory cues that signal different information, and hormonal influences may explain the conflicting results observed for the role of MHC in human sexual preference, and argue for the exploration of such caveats in less well-studied systems to discern between general patterns and qualities unique to humans.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Single nucleotide polymorphism (SNP) within tumor necrosis factor alpha (TNF-α) gene promoter (−308G/A TNFA) is associated with higher gene expression. The role of this SNP as a risk factor for spontaneous preterm birth has been assessed in some regions and the findings were significantly different between race and ethnic groups.
    Egyptian Journal of Medical Human Genetics 05/2015; 10. DOI:10.1016/j.ejmhg.2015.05.001